Investors & Media
Welcome to the Investor Relations and Public Relations division of Medigene AG. This is where you will find current information on a variety of subjects, including Medigene AG shares, company news, financial reports and key figures.
Neoantigen-based Therapies US Summit
Quarterly Statement Q3 2021
Cell Immunotherapies for Solid Tumors Summit
12th Annual Jefferies Global Healthcare Conference
LifeSci’s Virtual Corporate Access Event
Next Generation CAR-TCR Summit
Annual Report 2021
Good corporate governance is the basis of our decision-making and monitoring processes. It stands for responsible and value-based leadership and control of the Company for long-term success, goal-oriented and efficient cooperation between the Executive Board and Supervisory Board, respect for the interests of our shareholders and employees, consistently transparent and responsible corporate decisions and an appropriate risk management system.
Dr. Anna Niedl
Vice President Investor Relations & Corporate Communications
Phone: +49 89 2000 3333 01
Fax: +49 89 2000 33 2920